Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)
NCT ID: NCT05751031
Last Updated: 2023-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1200 participants
OBSERVATIONAL
2023-02-20
2024-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Raltegravir During the Third Trimester of Pregnancy
NCT02099474
Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
NCT01854762
Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants
NCT01828073
Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection
NCT01780831
The Effect of Pregnancy on the PK of Isentress®: A Longitudinal Investigation in the Second and Third Trimesters
NCT01251601
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)
Pregnant women living with HIV and their infants from 9 European cohorts and studies within the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)
Raltegravir
Raltegravir exposure in pregnant women living with HIV in routine clinical care. No study intervention administrated.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Raltegravir
Raltegravir exposure in pregnant women living with HIV in routine clinical care. No study intervention administrated.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UCL Great Ormond Street Institute of Child Health
OTHER
Fondazione Penta UK
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claire Thorne
Role: STUDY_CHAIR
Professor of infectious disease epidemiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire Saint Pierre
Brussels, , Belgium
Università degli studi di Firenze
Florence, , Italy
"Victor Babes" Hospital
Bucharest, , Romania
State Budgetary Institution of Health Protection Irkutsk
Arkhangelsk, , Russia
St Petersburg Republican Hospital
Saint Petersburg, , Russia
St. Petersburg State Budgetary Health Institution
Saint Petersburg, , Russia
Hospital San Joan de Deu
Barcelona, , Spain
Hospital Clinico San Carlos
Madrid, , Spain
University Hospital Zurich
Zurich, , Switzerland
University College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Luisa Galli
Role: primary
Luminita Ene
Role: primary
Luis Prieto Tato
Role: primary
Christian Kahlert
Role: primary
Claire Thorne
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Raltegravir
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.